The differential methylation in the IL-7 pathway in primary and recurrent GBM pairs of our own cohort and the TCGA cohort in the GO analyses prompted us to assess the DNA CpG methylation levels in the promoter + gene regions of IL-7 and its receptor (α subunit) in individual samples over time. The gene discussed is IL7; the disease is glioblastoma.